Synergen Inc. (NASDAQ:SYGN) of Boulder, Colo., has signed along-term lease with Du Pont on a facility in Glasgow, Del., tobe used to produce pharmaceutical products for clinical trialresearch, such as Antril interleukin-1-ra and SLPI elastaseinhibitor. The plant will begin operations in September andemploy about 20 people.

(c) 1997 American Health Consultants. All rights reserved.